GPT and metabolic dysfunction-associated steatotic liver disease: Consistent with the above findings in HFD‐induced MASLD mice, alnustone significantly decreased serum triacylglycerol, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels in mice with MASH (Figure 3b‐d), supporting an effect on alleviating liver injury.